New Human Biomarker Findings Support Mechanism of Action of Kerendia® (finerenone) in Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
WHIPPANY, N.J.--(BUSINESS WIRE)--Nov 2, 2023--
United States Semin Nephrol Christian Rommel American Kidney Fund National Diabetes Statistics Head Of Research
Source: eagletribune.com